Page 25 - Ryan LLC
P. 25
Complex large claims management and
stop-loss
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies:
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES HIGH RISK
DEFINED ONCOLOGY Pricing negotiation PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where NEONATAL
known impact can be made Rx cost containment
Claim audit and re-pricing
Plan design recommendations
Site of care review
ESRD/DIALYSIS HEMOPHILIA
Ryan, LLC. — Lockton Total Rewards Practice overview 25 Lockton Companies
stop-loss
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies:
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES HIGH RISK
DEFINED ONCOLOGY Pricing negotiation PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where NEONATAL
known impact can be made Rx cost containment
Claim audit and re-pricing
Plan design recommendations
Site of care review
ESRD/DIALYSIS HEMOPHILIA
Ryan, LLC. — Lockton Total Rewards Practice overview 25 Lockton Companies